超声与即时活检策略在非西班牙裔黑人和非西班牙裔白人绝经后出血中的管理比较
本研究基于文献和机构数据构建决策树模型,在模拟的10000例绝经后出血患者中比较即时活检策略(BBS)与超声策略(UBS)。UBS漏诊109例癌症,BBS漏诊70例;在观察到的随访率下,BBS每额外检出1例癌症需活检数在非西班牙裔黑人为33例、非西班牙裔白人为44例。作者认为BBS在随访不完美时价值更高,尤其合并肌瘤和非西班牙裔黑人患者。
要点
- 模拟10000例绝经后出血患者中,UBS漏诊109例癌症,BBS漏诊70例。
- 完美随访下,BBS较UBS每额外检出1例癌症需活检数:非西班牙裔黑人123例,非西班牙裔白人155例。
- 观察随访率下,BBS每额外检出1例癌症需活检数:非西班牙裔黑人33例,非西班牙裔白人44例。
核心结论
- 在观察到的/不完美随访水平下,BBS相比UBS具有更高价值,当存在肌瘤和非西班牙裔黑人患者时价值增强。
- 这些结果提示在绝经后出血初始评估时应提供子宫内膜取样。
研究设计与样本
- 基于文献和机构数据构建决策树模型,比较即时活检策略(BBS)与超声策略(UBS)在非西班牙裔黑人和非西班牙裔白人绝经后出血患者中的效果。
- 模拟队列为10000例绝经后出血患者。
- 主要结局为漏诊癌症诊断的概率和每额外检出1例癌症所需的增量活检数。
- 肌瘤患病率、子宫内膜可见性和种族使用机构患者水平数据建模。
- 假设异常超声后立即进行子宫内膜取样(完美随访),并另按机构观察到的随访率建模。
主要发现
- 在模拟的10000例绝经后出血患者中,UBS漏诊109例(95%预测区间85-159)癌症诊断,BBS漏诊70例。
- 与UBS相比,BBS每额外检出1例癌症需活检数:非西班牙裔黑人123例(95%预测区间45-265),非西班牙裔白人155例(95%预测区间47-398)。
- 在观察到的随访率下,BBS每额外检出1例癌症需活检数:非西班牙裔黑人33例(95%预测区间26-38),非西班牙裔白人44例(95%预测区间30-54)。
- 非西班牙裔黑人从BBS中获得更高价值(每额外检出1例癌症需活检数更少)相比非西班牙裔白人,尤其在存在肌瘤时。
临床怎么用
- 作者认为,在观察到的/不完美随访水平下BBS相比UBS具有更高价值,当存在肌瘤和非西班牙裔黑人患者时价值增强。
- 作者建议,在绝经后出血初始评估时应提供子宫内膜取样。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ultrasound-based evaluation of endometrial thickness to rule out endometrial cancer in patients with postmenopausal bleeding (PMB) is not sufficiently validated in the non-Hispanic Black (NHB) population. Differences in ultrasound performance between NHB and non-Hispanic White (NHW) patients may contribute to documented disparities in cancer-associated survival. METHODS: We developed a decision-tree model, informed by literature and institutional data, comparing an immediate biopsy-based strategy (BBS) to an ultrasound-based strategy (UBS) to evaluate PMB in NHB and NHW patients. Primary outcomes were the probability of a missed cancer diagnosis and incremental biopsies per additional cancer detected. Fibroid prevalence, endometrial visibility, and race were modeled using institutional patient-level data. Prompt endometrial sampling following abnormal ultrasound (perfect follow-up) was assumed; institutionally observed follow-up rates were alternatively modeled. RESULTS: In a simulated cohort of 10,000 patients with PMB, UBS missed 109 (95 % prediction interval (PI) 85-159) cancer diagnoses compared to 70 missed for BBS. Compared to UBS, BBS resulted in 123 (95 % PI 45-265) biopsies/additional cancer detected for NHB and 155 (95 % PI 47-398) for NHW. Under observed follow-up rates, BBS resulted in 33 (95 % PI 26-38) biopsies/additional cancer detected for NHB and 44 (95 % PI 30-54) for NHW. NHB derived higher value (fewer biopsies/additional cancer detected) from BBS than NHW, particularly with fibroids present. CONCLUSION: BBS has higher value compared to UBS under observed/imperfect levels of follow-up and enhanced value when fibroids are present and among NHB patients. These results suggest that endometrial sampling should be offered at time of initial evaluation for PMB.
引用
- Nolin AC, Atkins SL, Myers ER, et al. Ultrasound-based versus immediate biopsy-based management of postmenopausal bleeding in non-Hispanic Black and non-Hispanic White individuals. Gynecol Oncol. 2025. PMID: 39985869. doi:10.1016/j.ygyno.2025.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。